Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-11-25, Stock:LLY, The news for the past five days is as follows:
2020-11-18: NEWS1: Jardiance® reduced the risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and established cardiovascular disease in new analysis from the EMPA-REG OUTCOME® trial.NEWS2: 15 Largest Biotech Companies in the World.
2020-11-19: NEWS1: Baricitinib Receives Emergency Use Authorization from the FDA for the Treatment of Hospitalized Patients with COVID-19.NEWS2: What Awaits Pharma Giants in Last Lap of COVID-19 Vaccine Race?.NEWS3: Lilly and Ypsomed collaborate to advance an automated insulin delivery system for people with diabetes.
2020-11-20: NEWS1: Canada grants interim authorization to Eli Lilly's COVID-19 antibody drug.NEWS2: U.S. sees spike in daily COVID-19 cases, hospitalizations surge.NEWS3: Lilly's neutralizing antibody bamlanivimab (LY-CoV555) receives interim authorization from Health Canada as a treatment for COVID-19.NEWS4: Eli Lilly: Back From the Depths.NEWS5: Lilly/Incyte's Olumiant Gets FDA Emergency Nod for COVID-19.NEWS6: Pharma Stock Roundup: PFE COVID-19 Vaccine Final Analysis, FDA Updates & More.NEWS7: Eli Lilly Gets FDA Approval For COVID Treatment, WHO Doubts Gilead's Remdesivir.NEWS8: Lilly's arthritis drug and Gilead's Veklury receive FDA authorization as combination COVID-19 treatment.NEWS9: The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger.NEWS10: Lilly and Precision BioSciences Announce Genome Editing Research Collaboration and License Agreement.NEWS11: Eli Lilly’s Baricitinib Gets FDA Approval for Emergency Use with Remdesivir to Treat COVID-19 Patients.NEWS12: Eli Lilly's Arthritis Drug Gets Emergency Use Approval For Treatment Of COVID-19.
2020-11-23: NEWS1: BNP Paribas' Mark Howard on his 2021 market outlook.NEWS2: 'We still have a major problem with outpatient testing': Dr. Amesh Adalja.NEWS3: Regeneron Is Allowed to Sell the Covid Antibody It Served Trump and the Stock Is Rising.NEWS4: Here’s When the First Americans Could Get a Coronavirus Vaccine.
2020-11-24: NEWS1: Merck Sales Hit Hardest by Pandemic.NEWS2: Lilly to Participate in Evercore ISI 3rd Annual HealthCONx Conference.NEWS3: The Zacks Analyst Blog Highlights: Gilead, Eli Lilly, Incyte and Pfizer.NEWS4: Vir Biotech CEO Says His Covid-19 Medicine Offers Promise for Next Outbreak.NEWS5: Should Value Investors Choose Eli Lilly and Co (LLY) Stock?.NEWS6: Lilly's (LLY) Coronavirus Treatment Gets Interim Nod in Canada.

Answer: Decrease